TUDOR INVESTMENT CORP ET AL - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2023$2,683,551
+146702.6%
170,818
+54.0%
0.03%
+14.3%
Q1 2023$1,828
-100.0%
110,941
-74.7%
0.03%
-92.8%
Q4 2019$8,640,000
+15.1%
437,923
+0.3%
0.39%
+50.4%
Q3 2019$7,507,000
-71.2%
436,472
-65.9%
0.26%
-76.1%
Q1 2019$26,055,0001,279,0981.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders